Medmain Inc.

Pathology AI "PidPort" enables highly accurate and rapid presentation of analysis results and online pathological diagnosis

Staff
Osamu Iizuka (CEO)
Founded
2018
Sector
DeepTech, HealthTech & SportsTech, MedTech
Business Model
B2B, B2C,
Social Media
Product or Service
PidPort enables pathology screening through its unique AI-based image processing technology, and also has a remote pathology diagnosis function. PidPort supports the medical field with AI-based pathology image analysis.
Vision
Realize a better medical environment and "create a world where people can receive the medical care they need anytime, anywhere through technology.